PillRx only · Injection · Intravenous
Dopamine Hydrochloride
Dopamine Hydrochloride
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 4 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 3 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 6, 2017SHORTAGEDrug shortage: Dopamine Hydrochloride Injection (Hikma Pharmaceuticals USA, Inc.)
Dopamine Hydrochloride Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.